January 2007

Efficacy of Farabloc as an analgesic in primary fibromyalgia; Department of Medicine/Rheumatology, University of Munich, Munich, Germany; January 11, 2007.

Gerhard L. Bach - Department of Medicine/Rheumatology, University of Munich, Munich, Germany

Douglas B. Clement - Division of Sports Medicine, University of British Columbia,

"The goal of our study was to determine the efficacy of Farabloc, an electromagnetic shielding fabric compared to placebo fabric when worn as a nightgown, as an analgesic in patients hospitalized with fibromyalgia."

Click here to read the full article in a new window

The Efficacy of Farabloc, An Electromagnetic Shield, in Attenuating Delayed-Onset Muscle Soreness

Published in the Clinical Journal of Sport Medicine, January 2000, Volume 10, Number 1
PMID: 10695845 [PubMed - Indexed for MEDLINE]

View Complete Article in Acrobat Reader

A double Blind Cross-Over Study carried out by Jian Zhang M.Sc., Douglas Clement M.D. and Jack Taunton M.D. at the Allan McGavin Sports Medicine Centre, Division of Sports Medicine School of Human Kinetics and Department of Family Practice, at the University of British Columbia.

Objective

To determine the effect of Farabloc, a fabric with electromagnetic shielding properties, in attenuating the symptoms, signs and muscular strength of delayed onset muscle soreness (DOMS) induced by two exposures to eccentric exercise in human subjects.

Results

Repeated Measure Analysis of Variance was carried out for each of seven variables assessing fabric, order, time and all combinations VAS, EST, MDA, CPK, Mb, WBC and Neutral, all show highly significant fabric effect supporting the hypothesis of a difference between Farabloc and placebo groups.

This analysis shows that the order of Farabloc or placebo fabric use in stage 1 and 2 produces different results. This may be caused by training or learning effect but did not alter the overall influence of Farabloc

Conclusions

Farabloc shields high frequency electromagnetic fields thereby may reduce cellular excitability via increased cell membrane electric potential and reduced ionic pore activity plus suppressing free radical formation by inhibition of iron containing enzymes limiting the potential cascade of lipid peroxidation and inflammation in DOMS

Evidence for the Optimal Management of Acute and Chronic Phantom Pain: A Systematic Review

Published in the CLINICAL JOURNAL OF PAIN 2002; 18:84-92
PMID: 11882771 [PubMed - indexed for MEDLINE]

Go to abstract
OR
Click here for Complete Article in Acrobat Reader (PDF) format

Objectives

The objective was to examine the evidence to determine the optimal management of phantom limb pain in the preoperative and postoperative phase of amputations.

Methods

Trials were identified by a systematic search of MEDLINE, review articles, and references of relevant trials from the period 1966–1999, including only English-language articles. Included trials involved a control group, any intervention, and reported phantom pain as an outcome.

Conclusion

...
The implications of this systematic review for clinical practice are problematic. In early PLP (<2 weeks postoperatively), no treatments are clearly more effective than administration of opioid analgesics. Thus, clinicians could decide to use opioid analgesics at a dose that
should offer adequate pain relief with an acceptable level of risk of adverse effects. For late PLP (>2 weeks postoperatively), there is some evidence suggesting consideration
of Farabloc. It is unclear how readily regimens suggested for other neuropathic pain states can be applied to patients with PLP.

The Clinical Journal of Pain, Vol. 18, No. 2, 2002

top of page

Alleviation of pain with the use of Farabloc, an electromagnetic shield: A review

Published in BC Medical Journal  Volume 43, Number 10, December 2001, pages 573-577

Go to full text in Adobe PDF format. This will open a new window.

Objective

Review the research on the alleviation of pain by Farabloc, a fabric with electromagnetic shielding properties.

Conclusion

Farabloc, an electromagnetic shielding fabric, reduces pain in human subjects who suffer from phantom limb pain or delayed onset muscle soreness when assessed in placebo-controlled cross-over designed studies

top of page

The Efficacy of Farabloc In the Treatment of Phantom Limb Pain

Published in the Canadian Journal of Rehabilitation
Volume 6, Number 3, 1993 pp.155 --161 ISSN 0828-0827

Go to full text

Click Here To view a Power Point slide presentation of this Award Winning research paper. 

A clinical study undertaken by the University of British Columbia (1990 -- 1992)
Contract ordered by the British Columbia Ministry of Health.
The study was carried out by Tali A. Conine, DHSc, PT: Cecil Hershler, MD, pH, FRCP; Stacey A Alexander, B.Sc., PT and Robert Crisp, B.Sc., PT. With the assistance of Mr. Wayne Jones, statistical analyst, and Ms. Salima Jeraj, research assistant.

Over 60% of the patients studied reported their greatest pain relief using a Farabloc blanket or garment.

top of page

Farabloc in the Treatment of Phantom Pain, Rheumatic Pain and Other Painful Symptoms

Go to full text

A study carried out in 1987 by Prof. G.L. Bach (M.D.)
Formerly Professor and Chairman of Clinical Immunology and Rheumatology -
Chief University of Loyola --Medical Division at Cook County Hospital, Chicago, Illinois and the University of Loyola, Maywood, Illinois, USA

top of page

BC Medical Journal: Alleviation of Pain

Clinical Journal of Sports Medicine: Muscle Soreness ...

Clinical Journal of Rehabilitation: Phantom Limb Pain